Format

Send to

Choose Destination
See comment in PubMed Commons below
Horm Res Paediatr. 2012;77(3):200-4. doi: 10.1159/000334643. Epub 2011 Dec 22.

A novel GH1 mutation in a family with isolated growth hormone deficiency type II.

Author information

  • 1Medical Faculty Skopje, Skopje, Macedonia. gucevz@gmail.com

Abstract

BACKGROUND:

Four distinct familial types of isolated GH deficiency (IGHD) have been described so far.

OBJECTIVE:

We report a novel nonsense GH1 mutation in a father and a son.

PATIENTS:

Father's height was 137.3 cm (-6.79 SDS); mother's height was 157.3 cm (-1.86 SDS). By the age of 8.25 years, his height was 104.3 cm (-4.82 SDS) and his weight was 18.3 kg (-3.35 SDS). GH stimulation tests had low peak GH value of 6.5 ng/ml (proband) and 6.3 ng/ml (father). Other pituitary hormones and magnetic resonance imaging (MRI) of the pituitary region was normal in both patients. The proband received recombinant human GH (rhGH) treatment (30 μg/kg/day) and he grew 15.4 cm in 15 months.

RESULTS:

Sequencing of the GH1 gene revealed a novel heterozygous nonsense mutation in both the father and the son (c.199A>T), which introduces a stop codon in exon 3.

CONCLUSION:

We present a family with IGHD II, with severe short stature, no phenotypic characteristics of GHD and a novel nonsense mutation in exon 3 of the GH1 gene. As fibroblasts were unavailable, we used computer analysis and we propose a unique mechanism that combines aberrant splicing and derogated GH release from the pituitary with residual secretion of a bioinactive truncated GH peptide.

Copyright © 2011 S. Karger AG, Basel.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk